[ May 11 (Fri) ]
Licensing and Investment Strategies for Global (Bio) Pharmaceutical Development


To analysis of the global healthcare market and major policy of included countries for developing global new pharmaceuticals, and to share experts’opinion for recruiting licensing in/out strategy and its investment of promising field.


Session Chair Andy Jang, CEO, STASSETS INVESTMENT
Time Session Title
10 : 00 ~ 10 : 30 Global Healthcare Market Analysis
Michael Chen, Head of External Innovation Asia region, Merck
10 : 30 ~ 11 : 00 Healthcare Trends: a Canadian Perspective
Jean De Serres, Vice President, Paladin Labs
11 : 00 ~ 11 : 30 Partnering for a Healthy World: Pharma View on Academic and Biotech Collaborations
Yuan Hua Ding, Senior Director and Head , External R&D innovation, Asia, Worldwide eR&D , pfizer
11 : 30 ~ 13 : 00 Break
13 : 00 ~ 13 : 30 The Regulatory Reform and the Trend of Pharmaceutical Industry in China
Jiang Fei, Executive Director, Guijing Capital
13 : 30 ~ 14 : 00 Investment Value and Licensing Strategy in North American
Cedric Bisson, Partner, Teralys Capital
14 : 00 ~ 14 : 30 TIP for Successful Venture Investment
Kevin Lin, Vice Director, Fortune Venture Capital Co.Ltd.